This document provides guidance for final year medical students on examining the abdomen and hernias, investigating scrotal swellings, examining stomas, diagnosing small and large bowel obstructions, evaluating abdominal masses, and disorders of the colorectum and oesophagus/stomach. Key points covered include the nine abdominal quadrants, common incision sites, distinguishing inguinal hernia types, investigating hydroceles, and distinguishing simple from strangulated bowel obstructions. Common colorectal disorders like cancer, diverticulitis, and inflammatory bowel disease are also summarized.
Common Bile Duct (CBD) is a tube that carries bile from gallbladder or liver to the small intestine. Gallstone may develop when there is too much cholesterol or bilirubin inside gallbladder secreted by the liver. CBD stones may not have any signs & symptoms for months or even years. However, if the blockage becomes severe, then some signs & symptoms may be experienced. For more information, visit at http://gisurgery.info
Common Bile Duct (CBD) is a tube that carries bile from gallbladder or liver to the small intestine. Gallstone may develop when there is too much cholesterol or bilirubin inside gallbladder secreted by the liver. CBD stones may not have any signs & symptoms for months or even years. However, if the blockage becomes severe, then some signs & symptoms may be experienced. For more information, visit at http://gisurgery.info
Joanna Burgess, BSN, RN, CWOCN presented this informative webinar on living with, or preparing for an ostomy. Joanna shared insight and advice from her professional work as a wound, ostomy and continence nurse (WOCN), but she will also draw from her personal perspective from living with an ostomy.
Joanna will cover tips on how to care for your ostomy, how to prepare for surgery, diet and nutrition, ostomy reversal, and more! Joanna serves on the board of the United Ostomy Associations of America and chairs their advocacy committee.
Choledocholithiasis is one of the main causes for Obstructive Jaundice.In this ppt presentation, I have discussed the etiology, clinical features, complications, investigations and management of Choledocholithiasis. I have also included a mindmap and 2 algorithms for Choledocholithiasis. I hope you will find it very useful and interesting.
In this PPT presentation I try to teach many causes of Abdominal pain in various quadrants of the abdomen. Since it is individual case based teaching i concentrate only in the essential minimum an undergraduate medical student should know and you will have immersive learning experience.
Gallbladder is a small organ located under the liver. Its function is to aid in digestion of food by storing and secreting bile (a digestive juice) into the small intestine when food enters there. Gallstone Disease may develop when there is too much cholesterol or bilirubin inside gallbladder secreted by the liver. To know the signs & symptoms of Gallstone Disease. visit at http://gisurgery.info
This presentation explains in detail the definition, pathophysiology, signs & symptoms, management, and prognosis of intestinal obstruction, ileus, and volvulus.
This power point presentation slide is very helpful to my students and friend's to increasing the practical knowledge of different -different clinical Department.
An intestinal obstruction occurs when your small or large intestine is blocked. The blockage can be partial or total, and it prevents passage of fluids and digested food. If intestinal obstruction happens, food, fluids, gastric acids, and gas build up behind the site of the blockage.
Joanna Burgess, BSN, RN, CWOCN presented this informative webinar on living with, or preparing for an ostomy. Joanna shared insight and advice from her professional work as a wound, ostomy and continence nurse (WOCN), but she will also draw from her personal perspective from living with an ostomy.
Joanna will cover tips on how to care for your ostomy, how to prepare for surgery, diet and nutrition, ostomy reversal, and more! Joanna serves on the board of the United Ostomy Associations of America and chairs their advocacy committee.
Choledocholithiasis is one of the main causes for Obstructive Jaundice.In this ppt presentation, I have discussed the etiology, clinical features, complications, investigations and management of Choledocholithiasis. I have also included a mindmap and 2 algorithms for Choledocholithiasis. I hope you will find it very useful and interesting.
In this PPT presentation I try to teach many causes of Abdominal pain in various quadrants of the abdomen. Since it is individual case based teaching i concentrate only in the essential minimum an undergraduate medical student should know and you will have immersive learning experience.
Gallbladder is a small organ located under the liver. Its function is to aid in digestion of food by storing and secreting bile (a digestive juice) into the small intestine when food enters there. Gallstone Disease may develop when there is too much cholesterol or bilirubin inside gallbladder secreted by the liver. To know the signs & symptoms of Gallstone Disease. visit at http://gisurgery.info
This presentation explains in detail the definition, pathophysiology, signs & symptoms, management, and prognosis of intestinal obstruction, ileus, and volvulus.
This power point presentation slide is very helpful to my students and friend's to increasing the practical knowledge of different -different clinical Department.
An intestinal obstruction occurs when your small or large intestine is blocked. The blockage can be partial or total, and it prevents passage of fluids and digested food. If intestinal obstruction happens, food, fluids, gastric acids, and gas build up behind the site of the blockage.
There are marked variations in the incidence of gastric cancer worldwide.
The UK it is approximately 15 per 100000 per year
The USA 10 per 100000 per year
Eastern Europe 40 per 100 000 per year.
It is more common in Japan—70 per 1,00,000 population.
Common in males 2:1.
Decrease incidence in western world (Western Europe and US)—last four decades.
Please find the power point on Gastric Outlet Obstruction. I tried present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
3. 3
FIRST SENTENCE OF
ANSWER
• “I will take a full
history and perform a
full physical
examination.”
• Examiners expect this
• Remember to say that
you will do a PR, if
appropriate.
4. 4
Abdomen
• What are the 9
abdominal quadrants
called?
• How are the lines that
divide them defined?
7. 7
Hernias
• One of the few parts of final MB where surface
anatomy is crucial! Inguinal surface anatomy is used
to distinguish inguinal hernias into direct and indirect,
and to demonstrate femoral hernias.
• Most likely to get inguinal hernias, incisional hernias,
femoral hernias, para-umbilical hernias and epigastric
hernias.
8. 8
Inguinal surface anatomy
• A: Inferior
epigastric artery
• B: Femoral nerve
• C: Femoral artery
• D: Femoral vein
• E is the most
important …
• THE PUBIC
TUBERCLE
9. 9
Examination of the groin
• Usually means either a hernia, a testicular swelling or
lymph nodes.
• Groin Hernias:
• Either an inguinal lump or a scrotal lump you can’t get above.
If not clinically obvious, as the patient to stand and/or cough.
• Femoral hernias do not usually enter the scrotum.
• Try to gently reduce it.
• Surface anatomy: If it is below and lateral to the pubic
tubercle it’s a femoral hernia. If it’s superior or medial to
the pubic tubercle it’s an inguinal hernia. Inguinal is
commoner.
• Occlusion at the mid-inguinal point (i.e. halfway between the
pubic tubercle and the anterior superior iliac spine, i.e. the deep
ring) prevents an INDIRECT inguinal hernia from popping
out. In the middle-aged male, direct is commoner.
10. 10
Other hernias
• Incisional: 10% of hernias. Either reduceable or not.
• Para-umbilical: True umbilical hernias are rare after childhood. Para-
umbilical hernias are found in fat middle-aged women. Repaired
using Mayo repair
• Epigastric hernias: Fit young men
• Frequent questions:
• What is a hernia?
• What are the three commonest hernias?
• Who gets most inguinal hernias? Why?
• What is the commonest female hernia?
• What are the complications of hernias?
• What hernias occur ouside the abdomen?
• What is a Richter’s hernia?
11. 11
Scrotal swellings (i)
• CAN I GET ABOVE IT? If you can then it’s coming from the
scrotal structures.
• Common: Hydrocoeles, Epididymal cysts, spematocoeles.
• Uncommon: Tumours
• Examine as for any lump or bump:
• The 3 ‘S’s: Site, Size, Shape
• The 3 ‘C’s: Colour, Contour, Consistency
• The 3 ‘T’s: Tenderness, Tethering, Transillumination
• The ‘F’er: Fluctulence.
12. 12
Scrotal swellings (ii)
• Hydrocoeles: Surround the testis and make it difficult to feel.
Transilluminate!!!
• Spermatocoeles and epididymal cysts: Smaller, and arise from
adnexal structures. Do not obscure testis usually.
• Tumours: Stony hard. Arise from testis.
• Frequent questions:
• What investigation is appropriate for a newly diagnosed hydrocoele?
• What is a hydrocoele?
• What are the risk factors for testicular cancer?
• What blood tests would you consider for testicle carcinoma?
• What are the common types of testicle cancer and how are they
treated?
13. 13
Stomas (i)
• Most likely to be either an iliostomy or an end-colostomy.
• Less frequently, loop colostomy or ileal conduit(urinary
diversion)
• An iliostomy is in the RIF, and protrudes from the abdominal
wall. Most commonly fashioned following pan-proctocolectomy
in ulcerative colitis, or less frequently for caecal obstruction,
polyposis coli or severe Crohns colitis.
• An end colostomy is most frequently formed in the LIF, and
sits flush with the abdominal wall. Most commonly formed
after a Hartmann’s procedure or some rectal excisions.
14. 14
Stomas (ii)
• Loop colostomies are uncommon, and tend to be formed in the
epigastrium from the transverse colon, or the LIF from the sigmoid
colon. It is usually a palliative procedure for carcinomatous
obstruction.
• Ileal conduit urinary diversions look just like ileostomies, but the
bag will contain urine, even if only a little. They are usually formed
when the patient has had a cystectomy, often for carcinoma of the
bladder.
• Frequent questions:
• What is this?
• Why is it there?
15. 15
Stomas (iii)
• Complications:
• ILIOSTOMY:
• Metabolic: High output, B12 and Folate deficieny, Stones,
Anaemia.
• Anatomical: Stoma Prolapse and retraction, less frequently
stomal stenosis or parastomal herniation
• COLOSTOMY:
• Mostly Anatomical:
– EARLY: Stomal necrosis, ischaemia
– LATE: Stomal retraction, prolapse, stenosis, parastomal
herniation etc
16. 16
Small bowel obstruction
• Intestinal obstruction is characterised by vomiting,
abdominal distension, constipation and pain.
• In high obstruction, the vomiting tends to occur earlier then the
constipation. The reverse is the case for lower GI obstruction. In
high obstruction, the distension is minimal.
• The commonest causes are: Adhesions (60-80% of cases) and
Hernias (10-15%).
• Others include:
– Extrinsic: Volvulus, Non-GI neoplastic or inflammatory masses
– In the wall: Crohn’s disease, Intussussception, Strictures, Atresias.
– In the Lumen: Meconium ileus, Gallstones, Foreign body,
Faecolith.
17. 17
Small bowel obstruction
• Treatment:
• Assess for strangulation (Localised tenderness & pain)
• If simple (ie no strangulation):
– IV fluids, NBM, Analgesia
– FBP, U&E
– Monitor urine output
– NG aspiration for vomiting, if required.
• Remember, the rule is that 80% of simple small bowel
obstruction will settle with conservative treatment.
19. 19
Abdominal Masses
• Non-pathological: Gravid Uterus, Faeces in colon, Riedels lobe
of liver, kidneys in a thin person.
• Standard questiion is to distinguish a kidney from a spleen
• RIF:
– Sore: Appendix mass/abscess, Crohns mass
– Not Sore: Cancer (Caecal, Ovarian, Renal), Fibroids and ovarian
cysts, transplanted kidney.
• Epigastric
– Ca stomach, colon, liver, pancreas
• RUQ
– Liver, Colon, Right kidney, GB, Adrenal
20. 20
Colorectal Disorders
• Colorectal Carcinoma
• Important point is that the history is different depending on the
side of the colon the carcinoma is:
– RIGHT sided carcinomas Present insidiously because the colonic
contents are liquid and the colon relatively spacious at this point.
Presentation is with the development of anaemia : Fatigue,
malaise, weight loss, dark blood in stools.
– LEFT sided carcinomas present with the symptoms of narrowing
the lumen to more solid matter, Altered bowel habit, alternating
constipation and diarrhoea, brighter red PR bleeding.
– RECTAL carcinomas also have the symptoms of tenesmus and
passage of mucus PR
• Colonic carcinomas can also perforate and fistulate
21. 21
Colorectal Disorders
• Risk Factors:
– Longstanding Ulcerative colitis
– Polyposis Coli
– Family History
• Differential diagnosis:
– DIVERTICULAR DISEASE
• Any cause of large bowel obstruction
• PR Bleeding: Colorectal CA, Diverticular disease, Angiodysplasia,
Haemorrhoids, Anal fissure
• Investigations of choice: Barium enema and sigmoidoscopy,
with CT if carcinoma is confirmed.
22. 22
Colorectal Disorders
• TREATMENT:
• Surgery
• Chemotherapy with 5-Fluorouracil for tumours of stage Dukes
C or greater. Some would also give it for Dukes B
• Colorectal Carcinoma Complications: Bleeding, Perforation and
Fistulation into adjacent organs and obstruction…
24. 24
Colorectal Disorders
• DIVERTICULAR DISEASE:
• The great pretender. Can mimic colorectal carcinoma
remarkably. Both cause PR bleeding, can cause intestinal
obstruction, can perforate and can fistulate.
• Related to low-fibre diet
• Chronic symptoms investigated with Ba enema and
Sigmoidoscopy. (Aren’t they all)
• Often presents acutely with LIF pain and tenderness and
rebound. Settles with conservative Rx and Antibiotics usually.
• Majority do not require surgery, and are controlled with dietary
advice
26. 26
Colorectal Disorders
• Ulcerative colitis
• Palpable masses rare, never
fistulates
• Anorectal fissures and
infection occur less
frequently
• Medical Rx successful in
80%
• Surgery can be curative
• Crohn’s Disease
• Occasionally forms
inflammatory masses or
fistulae
• Anorectal sepsis common
• Medical Rx inadequate in
80%
• Surgery for complications
only
27. 27
Colorectal Disorders
• Medical treatment of ulcerative colitis:
• 5-ASA derivatives, such as Sulphasalazine or Mesalazine can be used
to reduce relapse rate. Delivered either orally, Enemas or suppository
form
• Prednisolone can be used topically as above, or can be given orally for
relapses, up to 60mg per day. It must be weaned off, rather than
stopped suddenly.
• Anti-diarrhoeals: Codeine, Loperamide.
• Endoscopy is used for surveillance
• Surgery is used for failure of medical Rx, For Carcinoma, Failure of
steroids to induce response in few days, and Toxicity: >8 bloody stools
per day, pulse >100, Temp > 38.5 C, Transverse colon dilated beyond
5cm and hypoalbuminaemia.
• Often a panproctocolectomy and iliostomy
28. 28
Colorectal Disorders
• Crohns disease
• Usually not accessable by topical preparations, so generally
treated with systemic 5-ASA derivatives or steroids where flare
up occurs.
• Surgery is often used for the complications: Abscess drainage,
resection of fistulas, and removal of strictured segments.
• Cannot be cured by surgery. Colonic crohns is a contraindication
for continent pouch procedures.
32. 32
Oesophagus and Stomach
• More likely to be used in
the long case setting, as
signs are uncommon, but
history is usually detailed.
• Haematemesis and
melaena.
• Use of NSAIDS eg
Aspirin, Smoking,
Alcohol, Steroids,
WARFARIN
• Remember to say PR
33. 33
Stomach and Oes. History (i)
• This is actually the history of upper GI bleeding, Upper abdominal
pain, and upper GI obstruction, with history.
• Upper GI Bleeding:
– Was it haematemesis or melaena
– Did one start before the other
– When did it start
– How many times has it happened
– When did it happen last
– Was it precipitated by anything
– How much blood was there
– Coffee-grounds vs fresh blood
– Did it make them collapse
– Have they felt tired / easily fatigued / easily short of breath… ANAEMIA!
34. 34
Stomach and Oes. History (ii)
• Upper GI obstruction: Oesophagus or Gastric?
– At the level of the Oesopagus: Dysphagia, regurgitation of food
– At the level of the Stomach: Early satiety, Forceful vomiting, Sucussion
splash if you’re lucky!
– Both give marked weight loss
• History
– Drug history: NSAIDS + Aspirin, Warfarin, Steroids.
– Smoking: Amount per day, and duration. “Have you ever smoked?”
– Alcohol: As for smoking.
– Family history
• Upper GI pain and differential later
35. 35
Stomach and Oesophagus signs
• Signs: THINK: Bleeding, Baccy and Booze.
• Bleeding: Pale conjunctivae, pallor. Melaena. (ie more chronic signs)
Unlikely to see tachycardia, hypotension etc, as this tends to be quite
acute. Remember NSAIDS and Warfarin. Trap for the unwary:
Guinness or Iron tablets give you black stools.
• Smoking: The most obvious is often nicotine stained fingers! Also
remember the signs of COAD: It implies a smoking history. Smoking
also significant in the context of cancer: Look for wasting, an LIF
mass, Hepatomegaly etc.
• Alcohol: This essentially means the signs of chronic liver disease.
36. 36
Stomach and Oesophagus
• Oral Questions relating to haematemesis / melaena:
• What risk factors did this patient have for Upper GI bleeding?
• Why are they on Aspirin / Warfarin / Steroids ?
• What investigations will you do AND WHY?:
• FBP, Coag, U&E, LFT, G&Csm 4 units, OGD.
• If the OGD is negative what investigation will you do (Melaena)?
• BARIUM ENEMA
• What are the commonest causes of upper GI bleeding:
• Gastritis, Duodenitis
37. 37
Stomach and Oesophagus
• What are the causes of upper GI bleeding:
• Oesophagus: Oesophagitis, Oesophageal erosions, Mallory-Weiss tears,
Oesphageal varices, Oesophageal carcinoma (rarely)
• Stomach: Gastritis, Gastric erosions, Gastric ulcers, Gastric carcinoma.
• Duodenum: Duodenitis, Duodenal Ulcers, Aorto-Enteric fistulas.
• How do you treat upper GI bleeding?
• Most settle with conservative Rx: IV fluids, NBM, PPI. Can use endoscopy
therapeutically for both ulcers and varices. Open resection of ulcer etc rare.
• What are oesophageal varices?
• What causes them?
• What are the other sites of porto-systemic anastamosis?
40. 40
Stomach and Oesophagus
• How would you investigate the patient with a tumour of the
stomach or oesophagus on OGD ?
• Stage them, using a CT scan of Chest, Abdomen and Pelvis. If
resectable then treat surgeically if possible. Radiotherapy is second-
line option for oesophagus. Many Gastric and oesophageal tumours are
irresectable, so remember to consider palliative care options such as
bypass and stenting, laser resection of oesophagus.
• What is Barrett’s Oesophagus?
• What is it’s significance?
• How do you manage it?
• What might cause dysphagia?
• What drugs are associated with upper GI bleeding?
42. 42
The Liver, biliary system and pancreas
• History features:
• Jaundice, Upper abdominal pain.
• Jaundice: The A to I varies from book to book, but I use:
– Alcohol
– Blood tranfusion
– Contact
– Drugs (eg Paracetamol)
– Extrahepatic
– Family History, Foreign Travel
– Gallstones
– Homosexuality
– Infections ( HBV, EBV, Leptospirosis)
43. 43
The Liver, biliary system and pancreas
• Upper Abdominal pain:
• Epigastric:
– Upper GI: Gastritis, Oesophageal reflux, Peptic Ulcer, Perforation of
gastric or duodenal ulcer.
– Hepatobiliary: Biliary Colic, Pancreatitis
– REMEMBER MYOCARDIAL INFARCTION
• Right Hypochondrium
– Hepatobiliary: Biliary Colic, Cholecystitis, Cholangitis, Hepatitis,
Pancreatitis, Fitz-Hugh-Curtis syndrome.
– Upper GI: Peptic Ulcer, Perforation of Ulcer
– Other Abdominal: Subphrenic abscess, Appendixitis, Renal Colic
– Extra-Abdominal: Right lower lobe pneumonia, Pulmonary embolus.
44. 44
The Liver, biliary system and pancreas
• Physical examination often involves looking for the signs of
chronic liver disease in the case of jaundice or pancreatitis.
Cholecystitis is most frequently abdominal signs only, if un-
complicated.
• Surgeons most frequently look after Cholecystitis and
Pancreatitis.
• Cholecystitis: Remember the 5 F’s! It gives the game away.
– Right Upper quadrant pain, aching/colicky, may radiate around to
back, often onset at night or in response to fatty foods, may be
associated with vomiting. Gallstones in the gallbladder do not
cause jaundice unless they move into the common bile duct.
– Complications: Jaundice, Pancreatitis.
45. 45
The Liver, biliary system and pancreas
• Physical examination usually only shows subcostal tenderness
and murphy’s sign. Rarely palpable. 5 F’s
• The investigation of cholecystitis is essentially the investigation
of upper abdominal pain.
• FBP, U&E, AMYLASE, LFT’s, Erect Chest X-Ray, Abdominal
film.
• Initial Rx: IV Fluids, Nil by mouth.
– Cefuroxime for infection. Most add Metronidazole as well.
Cholangitis is Jaundice, Fever and Rigors. This is known as
Charcot’s triad.
• Investigation: Ultrasound of abdomen. OGD if it’s normal.
• Treatment: Laparoscopic cholecystectomy or open
cholecystectomy. (Don’t use laparoscopic surgery if there are
adhesions, or a common bile duct stone)
46. 46
The Liver, biliary system and pancreas
• Stones in the common bile duct may
produce jaundice and pancreatitis.
They are suspected when ultrasound
detects a dilated common bile duct, or
visualised duct stones.
• An ERCP can the be carried out to
prove the fact, and the sphincter of
oddi divided to allow the stones to
pass harmlessly into the duodenum.
• They are not removed by a
laparoscopic cholecystectomy. At the
time of open surgery, an intraoperative
cholangiogram is performed to ensure
that none are present. If there are, then
they are removed with specialised
forceps.
47. 47
The Liver, biliary system and pancreas
• Pancreatitis:
• Presentation is similar to Cholecystitis, but pain is more centralised
and is more severe, possibly radiating to the back. Classically the
patient lies still with their knees bent. They are generally more unwell.
May be shocked, jaundiced.
• Physical signs are often absent or very scanty! Consider the signs of
chronic liver disease, Cullens sign and Gray-Turner’s sign. Abdominal
tenderness to palpation can be poorly localised and hard to define.
Pyrexia, Tachycardia.
• Initial investigations are the same as for cholecystitis: FBP, U&E, LFT,
Amylase, CXR, AXR. Amylase is considered diagnostic for
pancreatitis if it is greater than 1000 u/ml. Abdo Xray may show a
sentinel loop or loss of psoas shadow.
48. 48
The Liver, biliary system and pancreas
• Causes: Gallstones and Alcohol most common. Also GET
SMASH’D: Trauma and Surgery, Steroids, Mumps, AI, Scorpions,
Hyperlipidaemia and drugs.
• Treatment:
• Once diagnosis is established do an arterial blood gas and a serum calcium &
glucose. Treat any hypocalcaemia.
• IV fliuds, nil by mouth. Aim to keep urine output above 30 mls per hour.
Consider central line in elderly or CCF patients.
• Opiate analgesia
• NG tube
• Monitor
– Hourly urometer, Pulse and BP
– 12-hourly arterial bolld gases
– Daily FBP, U&E, Calcium and amylase
49. 49
The Liver, biliary system and pancreas
You must learn the Ranson criteria, as it is a measure of
severity. 0-2: 2% motality, rising to 100% for 7+
• AT PRESENTATION
• Age >55
• WCC>16
• Glucose>11
• LDH>350
• AST>60
• DURING 1st 48 HOURS
• Haematocrit falls >10%
• Urea rises >10
• Serum Ca2+ <2
• Base excess <-4
• PaO2 <8 kPa
• Fluid sequestered> 6 litres
50. 50
Jaundice
• Most surgeons look after post-hepatic jaundice. This type of
jaundice is charcterised by dark urine and pale stools. This is
because bilirubin products are not allowed to pass into the GI
tract via the biliary tree, but conjugated bilirubin is water
soluble and so darkens the urine.
• Jaundice is divided into pre-hepatic, hepatic and post-hepatic
aetiologies.
• Pre-Hepatic: Haemolysis, Heriditary eg Gilbert’s
• Hepatic: Cirrhosis, Carcinoma infiltration, Viral, Autoimmune,
Paracetamol and other drugs. Halothane is no longer used.
• Post-Hepatic (Obstructive): CBD gallstones, Pancreatic
carcinoma, Nodes in the porta-Hepatis, Cholangiocarcinoma.
Complication of lap chole?
51. 51
Jaundice
• The physical signs of chronic liver disease is a gob-standard
exam question. Remember to start at the hands and work up!
• Hands: Finger clubbing, Leukonechia, Palmar erythema,
Dupuytren’s, Asterixis
• Skin: Bruising, Spider Naevi, hair loss
• Face & Head: Jaundiced sclera. Constructional apraxia, Foetor
hepaticus.
• Chest: Gynaecomastia
• Abdomen: Enlarged liver or spleen, Ascites, Caput Medusae.
Remember to ascertain the nature of the liver edge, consistency,
tenderness. Bruits etc astronomically rare.
• Legs: Peripheral pitting oedema from hypoalbuminaemia.
52. 52
Jaundice
• Investigation of the jaundiced patient:
• FBP, U&E, LFT, Coagulation, Hepatitis
• Remember Macrocytosis as a sign of alcoholism
• In obstructive jaundice, the Alkaline Phosphatase will rise out
of proportion to the transaminases (These may be slightly up),
and the bilirubin is conjugated.
• Hepatocellular jaundice is characterised by marked
transaminase rise, and a mix of conjugated and unconjugated
bilirubin.
• Prehepatic Jaundice is unconjugated, (so not present in urine)
• Ultrasound: This will tend to separate the Hepatic and Post-
hepatic jaundices quite nicely also.
53. 53
Jaundice
• Questions:
• What are the causes of Cirrhosis?
• Alcohol and Hepatitis are the first things to say
• If pressed:
– Primary Biliary Cirrhosis, Autoimmune hepatitis
– Haemochromatosis and Wilson’s disease
– Drugs eg Methotrexate
– Budd-Chiari syndrome (Hen’s tooth), Cong Cardiac failure.
– Alpha-1-antitrypsin deficiency
• How would you prepare the jaundiced patient for surgery?
• Basically this means correcting any coagulation abn with FFP and/or
Vitamin K, and giving perioperative IV fluids to maintain a good urine
output (Hepatorenal syndrome more likely in the dehydrated)
55. 55
Breast lumps:
• Common Breast Lumps…
• Young Women: Fibroadenoma / Abscess
• Pregnant / recent sprog: Galactocoele / abscess
• Middle aged and elderly women: Cancer higher
up the differential diagnosis list.
• Investigation ***IN THIS ORDER***
1. Clinical examination
2. Mammogram (USS if premenopausal)
3. FNA aspiration
56. 56
Breast Cancer Treatment
• Local treatment:
– Usually lumpectomy/partial mastectomy if
feasble. Not feasable for central tumours, large
tumours or tumours in small breasts etc.
• Systemic treatment:
– Premenopausal usually chemotherapy
– Postmenopausal usually Tamoxifen.
(Remember risk of uterine CA)
58. 58
Aneurysm
• Mostly Aortic (Within abdo) Next most common is splenic
artery aneurysm. Think of Elderly male hypertensive
smokers with family history.
• Usually need repaired if greater than 5 centimeters in
diameter (Risk of bursting increases above this)
• Inv: FBP, U&E, ESR (?Inflammatory), CT scan, Chest X-
ray and ECG
• Need emergency CT if painful aneurysm – has it burst?
• Now can be repaired with endoluminal stenting in some
cases.
59. 59
Chronically Ischaemic lower limb:
• Signs:
– Absent pulses
– Colder than other limb
– Thin, Shiny skin
– Hair loss on leg
– Ulcers
– gangrene
• Symptoms:
– Claudication –
• At what distance.
• How long does it take to
disappear at rest
• On the flat or just uphill
• Rest pain?
• Relevant PMH:
– Smoking
– Diabetes
– Hypertension, Stroke, MI, etc
60. 60
Investigation
• Ankle-Brachial pressure index:
– Take systolic BP at brachial artery using doppler USS,
and compare it to the systolic BP at posterior tibial or
dorsalis pedis artery.
– Divide the ankle value by the arm value. Should be the
same. 0.5=Claudication, 0.3=Rest pain, 0.2= impending
gangrenous changes.
• Definitive main investigation is arteriography.
69. 69
Investigation of Haematuria
• Painless haematuria
is carcinoma until
proven otherwise
• Initial investigation
(For Anything) is
full history and
examination.
• PR!
70. 70
Investigation of Haematuria
• Blood Investigations
• FBP – Anaemic? White cell count raise indicative of
infection?, Enough platelets?
• U&E – Are their kidneys working? (Crude test)
• Coagulation screen – Haemophilia?, Warfarin?
• In Men … PSA
• REMEMBER MSSU – Direct microscopy
and culture.
71. 71
More Investigation
• Urinary Cytology:
– Not very sensitive, but an unequivocally positive cytology is
quite specific for TCC bladder.
• RADIOLOGY:
– IVP
– Ultrasound
– Both are very sensitive and specific, but USS better for small
peripheral renal lesions, and IVP better for renal pelvis and ureters.
• FLEXIBLE CYSTOSCOPY
72. 72
Bladder Cancer Incidence
• Males outnumber females by about 2.7 to 1
• Average age at diagnosis is 65 years.
• 85% confined to bladder at time of presentation.
• 70% will recur after treatment, and 30% of these will progress
• Risk Factors:
– SMOKING
– Chemical carcinogens – chemical, dye, rubber, petrol, leather and
printing industries are at increased risk. Also Cyclophosphamide
– Not Coffee
73. 73
Initial diagnosis and treatment
• Most are diagnosed using flexible cystoscopy under fresh air,
and haematuria investigations.
• Non-invasive tests such as PCR analysis, and Matrix-
metalloproteinase-9 are yielding some results with high
specificity and sensitivity, but remain research tools at present.
• IVP – Make sure there are no TCC in the renal pelvis or ureters.
For every 50-60 bladder carcinomata, there are 3 Renal pelvis
TCC’s and one ureteric TCC
• TURBT – Curative for early disease, also provides histology.
74. 74
Staging of TCC bladder
CIS Ta T1 T2 T3a T3b
mucosa
sub-
mucosa
detrusor
muscle
Peri-
vesical
fat
75. 75
Staging Continued
• Also Stage T4a, where the prostate is invaded, and T4b where
there is pelvic structure invasion. T3b has a worse prognosis
than T3a.
• Lymph nodes status, and presence or absence of metastases.
• Tumour Grade i.e. degree of preservation of cellular
architecture, mitotic figure number etc.
• Why bother staging? Treatment is tailored to stage of disease
76. 76
Treatment Options
• Ta Single, G1-2, Not recurrent: TURB
Multiple, recurrent, or high grade: TURB+Intravesical chemo
• T1 G1-2 TURB+Intravesical chemo
G3 TURB+BCG
• CIS TURB+BCG
• T2-T4 Radical Cystectomy
Radiotherapy
• N+ or M+ ?Chemotherapy - MVAC
77. 77
Surgery and Radiotherapy
• TURBT
• Radical cystectomy: Major intra-abdominal procedure. Can
divert urine either to an ileal conduit, or make a new bladder
from bowel or colon. Incidental lymph node mets found in 20-
35% 5 year survival a bit better than DXT – 65% for T2-T4
disease.
• Pelvic Radiotherapy: 20-40% 5 year survival, but 15% get local
complications, e.g. radiation cystitis or proctitis.
78. 78
Chemotherapy
• Intravesical
– Mitomycin response rate 40-50%. Consider single dose
intravesically post surgery rather than 6 week course. Occasionally
produces chemical cystitis.
– BCG decreases recurrence from 80 to 40%, and decreases
progression from 35% to 7%. Cystitis in 90% and haematuria in
33%
• Systemic
– MVAC (Methotrexate, Vinblastine, doxorubicin, cisplatin) 13-35%
response rate, but median survival rate is only one year
– Difficult to convince oncologists to give!
79. 79
The bottom line
• Five-year survival :
• Stage
• Ta 94%
• T1 69%
• T2 40%
• T3 31%
• T4 0
• Worse with increasing grade, and increased grade and stage
associated with increased risk of metastatic disease.
80. 80
Why Is a Spleen Not a Kidney?
• Very common exam question!
• Kidneys do not move with respiration
• Kidneys enlarge up & down, not to the RIF
• Kidneys are resonant to percussion
• Kidneys are ballottable
• Kidneys do not have a notch
• You can get above a kidney
81. 81
What Causes Big Kidneys?
Unilateral:
• Carcinoma
– Renal cell, transitional cell
in adults
– Nephroblastoma (wilm’s
tumour) in kids
• Hydronephrosis
– Tend to be chronic e.g. PUJ
obstruction, reflux
• Simple cysts
• Compensatory
hypertrophy
Bilateral
• Polycystic kidneys
• Bilateral hydronephrosis
• Amyloid … hen’s tooth
82. 82
Renal Cell Carcinoma
• Synonyms: hypernephroma, clear-cell carcinoma.
• Incidence: 2-3% of all adult cancers.
• Renal cell carcinoma is roughly 85% of all renal tumours, the
remainder being things like transitional cell carcinoma of the
renal pelvis, and renal sarcoma.
• Age peak of 40-70 years old.
• Males outnumber females 2:1
• Risk factors:
– Smoking.
– Others: Von-Hippel Lindau syndrome, horseshoe kidneys, adult
polycystic kidney disease, acquired renal cystic disease.
83. 83
RCC Aetiology and Presentation
• Arises from the cells of the proximal convoluted tubule.
• Presentation classically:
– Haematuria
– Flank pain
– Loin mass
• 50% diagnosed as incidental findings in 1995, during USS or
CT for other problem.
• 30% present with metastatic symptoms:
– Bone pain, dyspnoea, cough, etc.
– (Often to liver, lungs, bones, brain and adrenal glands)
Only true in 15%
84. 84
Why Physicians Like It
Paraneoplastic syndromes
• Erythrocytosis: (3-10%) from increased erythropoetin
production.
• Hypercalcaemia: (3-13%) either from a PTH-like substance,
or from osteolytic hypercalcaemia.
• Hypertension: (Up to 40%)
• Deranged LFT’s: Stauffer’s syndrome, from hepatotoxic
tumour products.
• Sundry others: Rarely produces ACTH (Cushing’s
syndrome), enteroglucagon (protein
enteropathy), prolactin (galactorrhoea),
insulin (hypoglycaemia) and
gonadotropins.
85. 85
Diagnosis and Staging
• Initial diagnosis:
– FBP, U&E, LFT.
– IVP and ultrasound.
– MSSU: direct microscopy.
• Staging:
– CT scan chest, abdomen and pelvis +/- head.
– Isotope bone scan.
• Rarely:
– Renal arteriography.
– Biopsy.
– Cavogram.
86. 86
Pathological Staging (1)
• May be different than your
textbooks. The TNM people
revised this in 1997, and it may
not be in older versions.
• Tumour:
– T1 <7cm, intra renal
– T2 >7 cm, intra renal
– T3 tumour extends into major
veins or perinephric tissues,
but not beyond gerota’s fascia
– T4 tumour beyond gerota’s
fascia
• Lymph nodes
– N0 no nodes
– N1 single lymph-node < 2cm
– N2 single lymph node 2-5cm
or multiple nodes <5cm
– N3 any nodes >5cm
• Metastases:
– M0 no metastases
– M1 distant metastases (often to
liver, lungs, bones, brain and
adrenal glands)
87. 87
Pathological Staging (2)
• And after all that:
Stage 1: T1 N0 M0
Stage 2: T2 N0 M0
Stage 3: T1-2 N1 M0
T3 n0-1 m0
Stage 4: T4 any N M0
Any T N2-3 M0
Any T any N M1
88. 88
Treatment
• Get rid of the primary tumour
– Radical nephrectomy
• Open or laparoscopic?
Laparoscopic has faster
patient recovery, but is time-
consuming in theatre.
– Partial nephrectomy for small
polar tumours, less than 4 cm
diameter.
– Embolisation.
– Consider small tumours below
2cm in unfit patients for
watching?
89. 89
Chemotherapy?
• Renal cell carcinoma has a track record of being unresponsive to
chemotherapy.
• Immunotherapy:
– Only works for clear cell type, the largest pathological group of RCC.
– Only used if lymph-node metastases, or metastases to solid organs.
Cerebral metastases are a contra-indication.
– Combination regimens based on cytokines
– Interleukin-2 19% response rate alone
– Interferon-α 11% response rate
– Together 25-30% response
– Combinations of interleukin-2, interferon-α and 5-fluorouracil have
produced response rates of 39% in one series.
• The main problem with immunotherapy is that it has a lot of side effects, such
as fever, hypotension, tachycardia, oliguria. You can end up in ICU from it, but
this is rare.
90. 90
The Bottom Line:
• Responses to immunotherapy tend to be short-lived, i.e. Months.
• Relapsers tend not to respond to more immunotherapy.
5-year survival:
• T1 88-100%
• T2 & t3a 60%
• T3b 15-20%
• T4 0-20%
Tumor stage T3 can be subdivided into
2 groups: T3a can invade the adrenal or
perinephric tissue, but remains within
gerota’s fascia, and T3b invades the
Renal vein or IVC.
91. 91
Other Renal Tumours (Adult) … Uncommon
• Sarcoma: females outnumber males by 2:1. Surgery only
effective therapy. Prognosis poor.
• Transitional cell carcinoma of the renal pelvis.
• Haematologic tumours (lymphoma deposits etc)
• Metastatic tumours: (In order of frequency)
– Lung
– Breast
– Stomach
• Non-tumours that masquerade as such:
– Oncocytoma
– Angiomyolipoma
– Others: leiomyomas, haemangiomas
92. 92
Symptoms of BOO
• “Irritative”
– Frequency, Urgency, Nocturia > 2 times per night
• “Obstructive”
– Hesitancy, Poor flow, Terminal dribbling.
• Others:
– Recurrent urinary tract infections as a consequence of
impaired bladder emptying
– Haematuria rarely.
• Can be scored using IPSS system
93. 93
Causes of impaired bladder emptying(i)
• Detrusor failure, i.e. “weak bladder”
– Think of the bladder with it’s nerve supply. Any
disorder of nervous control may impair emptying.
For example:
• Spine: Injuries, Disc prolapse, Spina bifida.
• Nerves: Diabetes, Multiple sclerosis.
• Bladder: Myogenic failure.
94. 94
Causes of impaired bladder emptying(ii)
• Outlet Obstruction i.e. “blocked bladder”
• Mostly a male phenomenon. Can be any cause from
bladder neck to outside world. For example:
– Prostatic enlargement
– Bladder neck hypertrophy (Often post TURP)
– Urethral strictures (Often post instrumentations, also STD)
– Meatal stenosis (As for strictures, also after botched
circumcisions and a condition called Balanitis Xerotica
Obliterans)
– In male infants: Posterior urethral valves
95. 95
Investigation of BOO symptoms
• History and examination
• Don’t forget to do PR!!!
• FBP, U&E, Glucose, MSSU
• Prostate specific antigen (PSA)
– Currently best blood-test for separating benign prostatic disease
from prostate cancer. It rises in cases of cancer. It can also rise with
urinary tract infections, and following episodes of urinary retention
or urinary instrumentation. Also slowly rises with age.
• Ultrasound of bladder (Is it emptying? If creatinine
abnormal then also ultrasound kidneys, looking for
obstructive uropathy)
• Urinary flow rate
96. 96
Benign Prostatic Hypertrophy
• PSA should be within normal
range or biopsies have shown no
carcinoma.
• Usually treated medically, unless
there is an absolute indication for
surgery:
– Refractory retention
– Recurrent UTI
– Bladder stones
– Obstructive uropathy
– Recurrent or persistent
haematuria
• Symptom control is only a relative
indication!
97. 97
Obstructive Uropathy
• Basically this is renal impairment caused by chronic
bladder outlet obstruction.
• It produces a detectable rise in creatinine, and
eventually can be seen on ultrasound as thinning of
the renal cortex.
• It means that the best treatment is operative relief of
obstruction.
98. 98
Acute Urinary Retention
• This is the end-stage of urinary outflow obstruction.
• Preceding outlet symptoms, with the ‘straw that
breaks the camel’s back’ often being an intercurrent
UTI, an episode of constipation, immobility or post-
operatively.
• Provided there is no obstructive uropathy, can be
started on medical treatment and catheter removed
after a day or two.
99. 99
Medical management of
prostatic obstruction
• Two broad groups of drugs:
– Alpha-blockers: These produce smooth muscle
relaxation within the prostate, and so widen the
outflow tract. Older generation drugs have been
associated with postural hypotension, but newer drugs
such Tamsulosin have minimised this.
– 5-alpha reductase inhibitors: blocks testosterone
metabolism to produce a 25% decrease in prostate
volume. Better for large ‘fleshy’ glands. 5% of patients
get hot flushes, and can also cause gynaecomastia.
Finasteride is the only drug in this group.
100. 100
Surgical management of
prostatic obstruction
• A variety of operations has been tried, such as prostatic
microwave, cryoablation, and transurethral incision of the
prostate.
• However, none has replaced TURP (Trans-urethral resection of
prostate), which remains the gold standard.
• TURP is not always successful, however. The most common
early complication is failure to void after catheter removal (6%).
There is also a small risk of incontinence from external sphincter
damage.
• And finally: After TURP erectile failure may be produced, and
ALWAYS retrograde ejaculation is caused.
101. 101
Prostatic carcinoma
• 4th commonest cancer death, after lung,colon and breast.
• Rare before age 40, peak incidence in 70’s.
• 70% arise in the peripheral zone of the prostate.
• Most often found on PR or PSA testing
• 40% have metastases at the time of diagnosis.
103. 103
Further investigation
• Is the prostate cancer
1. Metastatic ( Only treatable with Hormones)
2. Locally advanced (Hormones or radiotherapy)
3. Confined to the prostate (Hormones, Radio or Surgery)
• Staging of prostate cancer requires an isotope
bone scan. In patients under 75 years, where
surgery or radiotherapy are being considered, a
CT scan is also required.
104. 104
Staging (TNM)
• T1a: Tumor in <5% TURP specimen,
incidental finding.
• T1b: Tumor in >5% TURP specimen,
incidental finding.
• T1c: Tumor non-palpable, diagnosed on
biopsy.
• T2a: Palpable, half a lobe or less
• T2b: Palpable, half to all of one lobe
• T2c: Palpable, involves both lobes.
• T3a: Unilateral extracapsular extension
• T3b: Bilateral extracapsular extension
• T3c: Tumor invades seminal vesicles
• T4a: Invades bladder neck, external
sphincter or rectum
• T4b: Invades levator muscles, or is
fixed to pelvic side-wall.
• N0: No lymph node metastases
• N1: Single node metastasis, below
2cm in size
• N2: Mets to a single node between
2 and 5 cm, or multiple nodes less
than 5cm.
• N3: Lymph node metastasis > 5cm
• M0: No Metastases.
• M1: Metastases
105. 105
Treatment - Surgery
• For prostate cancer without metastases, which is confined
to the prostate, PSA is below 15, and age below 70,
consider RADICAL PROSTATECTOMY.
• Major intra-abdominal procedure, with significant
morbidity. Almost inevitably produces total erectile failure,
and a variable degree of incontinence. Incontinence tends
to improve / resolve with pelvic floor exercises.
• 5 year disease-free survival for T2 cancer with surgery is
80%
106. 106
Treatment - Radiotherapy
• Consider in males with disease that has spread locally outside the
prostate below age 75. Also for prostate confined disease in men below
70 years, unfit for surgery, and without metastases.
• Can be given as external beam or brachytherapy (implanted radioactive
particles within the prostate)
• Complications:
– Bladder: Frequency, Urgency, Haematuria.
– Bowel: Diarrhoea, Tenesmus, PR bleeding.
– Skin: Rash
– Rarely, fistulas may be caused.
• 5 year disease free survival for T2 disease is 70% (Slightly lower than
for surgery)
107. 107
Treatment - Hormones
• Prostate carcinoma is dependant on testosterone to survive. The
medication used attempts to block testosterone synthesis. They are
used in cases of metastatic disease or age >75 years or unfitness for
either surgery or radiotherapy for localised disease.
– Gonadotropin analogues: Goserelin, Leuprolin. Often given as monthly or
3-monthly injections. Initially produce a tumour flare, so can only be
started after several days of an anti-androgen.
– Anti-androgens: Flutamide, Bicalutamide, Cyproterone acetate. Tablet
form once daily.
– Both of these medication groups produce significant side-effects: most
often hot-flushes, erectile failure, loss of libido, and gynaecomastia.
• Treatment can be combined, using both a GNRH analogue and an anti-
androgen. On average a 2-year response is achieved until the
development of ‘Hormone-resistance’. Alterative drugs for advanced
disease include Oestrogens and Estramustine.
108. 108
Ooh, Controversy!
• In elderly men, i.e. age greater than 75, there is an argument for
not investigating an asymptomatically raised PSA.
• The reason is that at this age, there is a significant chance they
will die of something else, and the only treatment would be
Hormonal manipulation anyway. Some argue that treatment
should be witheld until the development of outflow symptoms
or metastatic discomfort, and then instituted.
• The idea is to avoid needlessly treating and worrying elderly
men
109. 109
Urinary tract Calculi
• Ureteric Calculi: Most pass without difficulty, especially if
below 5mm in diameter. Above 7mm they are unlikely to pass.
• If calculi are not passing, or if they are causing blockage of the
kidney as shown on IVP, then they can be removed
endoscopically using a Ureteroscope and either Laser or EHL or
basket extraction. If there’s a lot of ureteric swelling then a stent
can be left in for 4-6 weeks and then removed.
• Ureteric calculi can be a symptom of a raised serum Calcium, so
remember to check it!
110. 110
Urinary tract Calculi
• Renal Calculi:
• Generally present either as a cause of recurring infections or a
cause of pain in the loin or flank. If large enough, they can
seriously compromise renal function. This can be detected using
a DMSA scan.
• In a functioning kidney, stones up to about 2cm can be
fragmented with ESWL sessions, which may be multiple. Larger
stones or multiple stones may be dealt with operatively using
PCNL, where a tube is inserted though the flank into the renal
pelvis, and the stones surgically fragmented and removed. Very
large stones may need to be removed using an open
pyelolithotomy.
• If the kidney is non-functioning then it can be removed.